Miwa Haruo, Sugimori Kazuya, Yonei Shoichiro, Yoshimura Hayato, Endo Kazuki, Oishi Ritsuko, Funaoka Akihiro, Tsuchiya Hiromi, Kaneko Takashi, Numata Kazushi, Maeda Shin
Gastroenterological Center, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Department of Gastroenterology, Yokohama City University, Yokohama 236-0004, Japan.
Diagnostics (Basel). 2024 Apr 24;14(9):882. doi: 10.3390/diagnostics14090882.
The differential diagnosis of solid pancreatic lesions (SPLs) using B-mode endoscopic ultrasonography (EUS) is challenging. Detective flow imaging (DFI) offers the potential for detecting low-flow vessels in the pancreas, thus enhancing diagnostic accuracy. This retrospective study aimed to investigate DFI-EUS findings of SPLs and analyze their differential diagnostic accuracy for pancreatic cancer. We included 104 patients with pathologically confirmed SPLs who underwent EUS between April 2021 and June 2023. Expert endosonographers, blinded to the patients' clinical data, evaluated images obtained through B-mode, eFLOW, and DFI-EUS. The frame rate and vessel detection sensitivity were compared between eFLOW and DFI, and the diagnostic criteria for pancreatic cancer were established. The visualization rate for vessels in SPLs was significantly higher with DFI-EUS (96%) compared to eFLOW (27%). Additionally, DFI showed a superior frame rate, sensitivity (99%), and accuracy (88%) for detecting pancreatic cancer, although with a modest specificity (43%). On DFI-EUS, characteristics such as hypovascularity, peritumoral vessel distribution, or spotty vessel form were suggestive of pancreatic cancer. DFI-EUS significantly improved the visualization of vascular structures within the SPLs, highlighting its efficacy as a diagnostic modality for pancreatic cancer.
使用B型内镜超声(EUS)对实性胰腺病变(SPL)进行鉴别诊断具有挑战性。检测血流成像(DFI)为检测胰腺低血流血管提供了可能,从而提高诊断准确性。这项回顾性研究旨在调查SPL的DFI-EUS表现,并分析其对胰腺癌的鉴别诊断准确性。我们纳入了104例在2021年4月至2023年6月期间接受EUS检查且病理确诊为SPL的患者。经验丰富的内镜超声检查医师在不知道患者临床资料的情况下,对通过B型、eFLOW和DFI-EUS获得的图像进行评估。比较了eFLOW和DFI之间的帧率和血管检测灵敏度,并建立了胰腺癌的诊断标准。与eFLOW(27%)相比,DFI-EUS对SPL中血管的可视化率显著更高(96%)。此外,DFI在检测胰腺癌方面显示出更高的帧率、灵敏度(99%)和准确性(88%),尽管特异性一般(43%)。在DFI-EUS上,血管减少、肿瘤周围血管分布或点状血管形态等特征提示胰腺癌。DFI-EUS显著改善了SPL内血管结构的可视化,突出了其作为胰腺癌诊断方式的有效性。